From Crisis to Clarity

Building the Agentic Enterprise
for Pharma & SMEs.

I combine the rigor of a Pharma Executive, the vision of a Strategic Investor, and the technical capability to build Custom AI Agents that solve complex operational problems.

Real Problems. Agentic Solutions.

Theory is easy. Execution in a crisis is hard. In 2025, I took over RB Pharma in a critical state: paralysis, financial distress, and a skeleton team.

Instead of traditional consulting, I deployed custom AI Agents to automate bureaucracy and clarify data, freeing me to focus on the human strategy.

"I don't just advise on AI. I build the agentic workflows that recover businesses."

The RB Pharma Turnaround (8 Months)

Revenue Generated
€1.2 Million
Verified
Team Reconstruction
2 8
High-Performance Elements
(Rebuilt from collapse; prev. 15 FTEs)
Tech Enabler
> Custom Agents for Treasury, Ops & Regulatory Compliance
> MVP "Wixmed" kept active and operational
The Strategic Vision

The "Agentic Velocity" Model

Crisis management stabilizes the ship. This is where I steer it next. My Agentic Workflow model is designed to compress supply chain latency from days to hours.

Target Response Velocity

Standard Industry State: Manual processes bottlenecking the supply chain.

Target Velocity
168h

The Hybrid Profile

Competency Matrix

2025

The Turnaround Strategist

RB Pharma

Leveraged Agentic AI to stabilize operations and deliver €1.2M revenue.

2017 - 2025

The Corporate Agilist

Cencora

Navigating a €750M multinational giant with strategic marketing leadership.

2013 - Present

Entrepreneurial Investor

Portfolio: Atelier 560, Melt

Building resilient assets with skin in the game across retail and pharma.